8 completed, 6 recruiting, 2 active not recruiting, 1 not yet recruiting. 6 Not applicable, 4 Phase 2, 2 Phase 1, 1 Phase 3.
Follow Lip Neoplasms: new trials by email Literature Review of Lip Neoplasms trials Research Report on Lip Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) Hypofractionated Stereotactic Body Radiotherapy (SBRT), Pembrolizumab, Ficerafusp alfa - Head and Neck Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Washington University School of Medicine | 45 | 2026-11-30 | 2026-11-03 |
| Microbiome in Head and Neck Squamous Cell Carcinoma Metagenomic sequencing, Metabolic analysis - Head and Neck Cancer, Lip Cancer | Recruiting | University of Colorado, Denver | 60 | 2025-05-23 | 2026-02-24 | |
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer | Withdrawn | Travera Inc | 2024-11-01 | 2024-11-25 | ||
| Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors DaRT- Diffusing Alpha-emitters Radiation Therapy - Skin Cancer, Cutaneous Tumor | Not applicable | Recruiting | Alpha Tau Medical LTD. | 80 | 2022-04-01 | 2026-06-16 |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Terminated | Alpha Tau Medical LTD. | 2 | 2021-07-08 | 2025-12-08 |
| T1 Squamous Cell Carcinomas of the Lip Lip, Lip Cancer | Unknown | Maastricht University Medical Center | 300 | 2021-04-01 | 2023-08-16 | |
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Completed | Alpha Tau Medical LTD. | 2 | 2020-12-22 | 2025-12-02 |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Recruiting | Alpha Tau Medical LTD. | 56 | 2020-12-22 | 2026-06-16 |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Recruiting | Alpha Tau Medical LTD. | 30 | 2020-10-21 | 2025-12-02 |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Active not recruiting | Alpha Tau Medical LTD. | 30 | 2018-12-31 | 2026-04-06 |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene A166 - HER2-positive Breast Cancer, HER2 Gene Mutation | Phase 1 / Phase 2 | Completed | Klus Pharma Inc. | 49 | 2018-07-16 | 2023-08-03 |
| Serum Lipid Profile and Lip Squamous Cell Carcinoma Lipid Profile, Lipids | Completed | Akdeniz University | 56 | 2018-01-01 | 2025-06-06 | |
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma Durvalumab, Carboplatin, Nab-paclitaxel - Carcinoma, Squamous Cell, Oral Cancer | Phase 2 | Active not recruiting | UNC Lineberger Comprehensive Cancer Center | 39 | 2017-12-19 | 2026-02-23 |
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma Cetuximab, Ficlatuzumab - Head and Neck Basaloid Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 2 | Completed | University of Arizona | 78 | 2017-12-05 | 2024-09-04 |
| Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making OncAlert - Palatal Neoplasms, Lip Neoplasm | Completed | Vigilant Biosciences, Inc. | 893 | 2017-09-07 | 2021-08-12 | |
| Integrated Cancer Repository for Cancer Research Pancreatic Cancer, Thyroid Cancer | Recruiting | University of Nebraska | 999999 | 2013-11-01 | 2026-06-29 | |
| Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer Larynx Cancer, Lip Cancer | Completed | Mahesh Kudrimoti | 115 | 2007-08-01 | 2021-07-14 | |
| A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations Mouth Cancer, Lip Cancer | Completed | Stanford University | 49 | 2001-11-01 | 2015-05-27 | |
| Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Tumor biopsy, Phlebotomy - Head and Neck Cancer, Lung Cancer | Recruiting | Stanford University | 200 | 1998-09-01 | 2026-07-01 | |
| Phase II Trial of Allovectin-7® for Head and Neck Cancer Allovectin-7® - Head and Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx | Phase 3 | Completed | Vical | 2008-06-24 |
Carcinoma, Squamous Cell (11) · Mouth Neoplasms (10) · Squamous Cell Carcinoma of Head and Neck (9) · Tongue Neoplasms (9) · Skin Neoplasms (8) · Head and Neck Neoplasms (7) · Oropharyngeal Neoplasms (7) · Carcinoma, Basal Cell (6) · Laryngeal Neoplasms (6) · Sarcoma, Kaposi (5) · Soft Tissue Neoplasms (5) · Lung Neoplasms (4) · Breast Neoplasms (3) · Esophageal Neoplasms (3)
Lip Diseases (20) · Mouth Diseases (20) · Neoplasms by Site (20) · Stomatognathic Diseases (20) · Neoplasms (19) · Neoplasms by Histologic Type (15) · Neoplasms, Glandular and Epithelial (15) · Head and Neck Neoplasms (13) · Carcinoma (12) · Neoplasms, Squamous Cell (11) · Mouth Neoplasms (10) · Otorhinolaryngologic Diseases (10) · Otorhinolaryngologic Neoplasms (9) · Pharyngeal Diseases (9) · Skin Diseases (9)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Allovectin-7 (1) · Blood Specimen Collection (1) · Carboplatin (1) · Cetuximab (1) · Cisplatin (1) · Metabolic Flux Analysis (1) · Phlebotomy (1) · Radiotherapy, Intensity-Modulated (1) · durvalumab (1) · ficlatuzumab (1) · pembrolizumab (1)
Alpha Tau Medical LTD. (6) · Stanford University (2) · Akdeniz University (1) · Klus Pharma Inc. (1) · Maastricht University Medical Center (1) · Mahesh Kudrimoti (1) · Travera Inc (1) · UNC Lineberger Comprehensive Cancer Center (1) · University of Arizona (1) · University of Colorado, Denver (1) · University of Nebraska (1) · Vical (1) · Vigilant Biosciences, Inc. (1) · Washington University School of Medicine (1)
United States (11) · Israel (4) · France (1) · Italy (1) · Netherlands (1) · Turkey (Türkiye) (1)
Quynh-Thu Le (2) · Alper Sindel, DDS, PhD (1) · Aron Popovtzer (1) · Aron Popovtzer, M.D (1) · Busehan Bilgin, DDS (1) · Eldar Rasljanin, DDS (1) · Jared Weiss, MD (1) · Jordi Rodon Ahnert, MD, PhD (1) · Julie E. Bauman, MD, MPH (1) · K Mosterd, MD, PhD (1) · Kurt Fisher, MD, PhD (1) · Laura Eibenschuz, MD (1) · Mahesh Kudrimoti, MD (1)
P30CA023074 (1), P50CA261605 (1), R01DE029672 (1)